参考文献/References:
[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. A cancer journal for clinicians,2018,68(6):394-424.
[2]CULP M B,SOERJOMATARAM I,EFSTATHIOU J A,et al. Recent global patterns in prostate cancer incidence and mortality rates[J]. European urology,2020,77(1):38-52.
[3]RUETALO N,ANDERS S,STOLLMAIER C,et al. The WW1 domain enhances autoinhibition in smurf ubiquitin ligases[J]. Journal of molecular biology,2019,431(24):4834-4847.
[4]SCHEFFNER M,KUMAR S. Mammalian HECT ubiquitin-protein ligases:biological and pathophysiological aspects[J]. Biochimica et biophysica acta,2014,1843(1):61-74.
[5]ZOU X,LEVY C G,BLANK M. Molecular functions of NEDD4 E3 ubiquitin ligases in cancer[J]. Biochimica et biophysica acta,2015,1856(1):91-106.
[6]DAVID D,NAIR S A,PILLAI M R. Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression[J]. Biochimica et biophysica acta,2013,1835(1):119-128.
[7]KLUPP F,GIESE C,HALAMA N,et al. E3 ubiquitin ligase Smurf2:a prognostic factor in microsatellite stable colorectal cancer[J]. Cancer management and research,2019,11:1795-1803.
[8]TOMAS A,FUTTER C E,EDEN E R. EGF receptor trafficking:consequences for signaling and cancer[J]. Trends in cell biology,2014,24(1):26-34.
[9]DAVID D,JAGADEESHAN S,HARIHARAN R,et al. Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner[J]. Cell division,2014,9:2.
[10]DAVID D,SURENDRAN A,THULASEEDHARAN J V,et al. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2,and its role in breast cancer progression[J]. BMC cancer,2018,18(1):284.
[11]BLANK M,TANG Y,YAMASHITA M,et al. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape andgenome stability through RNF20[J]. Nature medicine,2012,18(2):227-234.
[12]RAMKUMAR C,KONG Y,CUI H,et al. Smurf2 regulates the senescence response and suppresses tumorigenesis in mice[J]. Cancer research,2012,72(11):2714-2719.
[13]EMANUELLI A,MANIKOTH A D,KOGANTI P,et al. Altered expression and localization of tumor suppressive E3 ubiquitin ligase SMURF2 in human prostate and breast cancer[J]. Cancers(Basel),2019,11(4):556.
[14]WANG Z,WANG J,LI X,et al. Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1,Smurf1 and Smurf2[J]. International journal of oncology,2014,45(4):1469-1478.
[15]HELLWINKEL O J,ASONG L E,ROGMANN J P,et al. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma[J]. Prostate cancer and prostatic diseases,2011,14(1):38-45.
[16]TU Y,CHEN C,PAN J,et al. The ubiquitin proteasome pathway(UPP)in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis[J]. International journal of experimental pathology,2012,5(8):726-738.
[17]JANG H H. Regulation of protein degradation by proteasomes in cancer[J]. Journal of cancer prevention,2018,23(4):153-161.
[18]HE M,ZHOU Z,SHAN A A,et al. The emerging role of deubiquitinating enzymes in genomic integrity,diseases,and therapeutics[J]. Cell bioscience,2016,6:62.
[19]KACHROO P,LEE M H,ZHANG L,et al. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer[J]. Journal of experimental & clinical cancer research:CR,2013,32(1):97.
[20]PAN C M,WANG M L,CHIOU S H,et al. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings[J]. Oncotarget,2016,7(37):60395-60406.
相似文献/References:
[1]皮玉瑞,李同辉,陈秀彬,等.前列腺癌细胞中多烯紫杉醇下调Smad3不依赖TGF-β1信号[J].南京师大学报(自然科学版),2016,39(03):89.[doi:10.3969/j.issn.1001-4616.2016.03.015]
Pi Yurui,Li Tonghui,Chen Xiubin,et al.Docetaxel Down-Regulation of Smad3 Expression in Prostate CancerCell Lines Independent of TGF-β1 Signaling[J].Journal of Nanjing Normal University(Natural Science Edition),2016,39(02):89.[doi:10.3969/j.issn.1001-4616.2016.03.015]
[2]康 丹,吴朝蒙,曹润怿,等.根皮素引起前列腺癌LNCaP细胞发生凋亡的机制研究[J].南京师大学报(自然科学版),2017,40(02):43.[doi:10.3969/j.issn.1001-4616.2017.02.008]
Kang Dan,Wu Zhaomeng,Cao Runyi,et al.Molecular Mechanism of Phloretin-Induced Apoptosisin Prostate Cancer LNCaP Cells[J].Journal of Nanjing Normal University(Natural Science Edition),2017,40(02):43.[doi:10.3969/j.issn.1001-4616.2017.02.008]
[3]高婉莉,杨 黎,刘 姗,等.抗CD3×CD87单链双特异抗体介导的单个核细胞对前列腺癌细胞杀伤作用的体外研究[J].南京师大学报(自然科学版),2017,40(02):51.[doi:10.3969/j.issn.1001-4616.2017.02.009]
Gao Wanli,Yang Li,Liu Shan,et al.Bispecific Anti-CD3×Anti-CD87 Single-Chain Antibody Mediates CytolyticActivity of Mononuclear Cells Against CD87-Positive Prostate Cancer in vitro[J].Journal of Nanjing Normal University(Natural Science Edition),2017,40(02):51.[doi:10.3969/j.issn.1001-4616.2017.02.009]
[4]田 倩,曹润怿,王方方,等.CXCL13参与AR促进前列腺癌细胞体内异种移植瘤的生长[J].南京师大学报(自然科学版),2018,41(03):70.[doi:10.3969/j.issn.1001-4616.2018.03.012]
Tian Qian,Cao Runyi,Wang Fangfang,et al.CXCL13 Involved in AR-Mediated Prostate Cancer CellXenograft Tumor Proliferation in vivo[J].Journal of Nanjing Normal University(Natural Science Edition),2018,41(02):70.[doi:10.3969/j.issn.1001-4616.2018.03.012]
[5]贺稳政,吴庆新,刘 平.NCAPD3激活AKT-FOXO信号通路抑制前列腺癌细胞的凋亡[J].南京师大学报(自然科学版),2021,44(03):90.[doi:10.3969/j.issn.1001-4616.2021.03.014]
He Wenzheng,Wu Qingxin,Liu Ping.NCAPD3 Inhibits Apoptosis of Prostate Cancer Cellsby Activating AKT-FOXO Signaling Pathway[J].Journal of Nanjing Normal University(Natural Science Edition),2021,44(02):90.[doi:10.3969/j.issn.1001-4616.2021.03.014]
[6]刘倩梅,柯 敏,何馨媛,等.NCAPD3通过EZH2促进前列腺癌发生发展[J].南京师大学报(自然科学版),2021,44(04):53.[doi:10.3969/j.issn.1001-4616.2021.04.007]
Liu Qianmei,Ke Min,He Xinyuan,et al.NCAPD3 Promotes the Occurrence and Development ofProstate Cancer Through EZH2[J].Journal of Nanjing Normal University(Natural Science Edition),2021,44(02):53.[doi:10.3969/j.issn.1001-4616.2021.04.007]